{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "This retrospective cohort study was conducted at a single academic institution."
      },
      "Participants": {
        "score": 2,
        "evidence": "involving patients who underwent open surgery for gynecologic malignancies using ERAS protocols from March 2016 to December 2018."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were categorized into two cohorts based on the presence or absence of postoperative AKI within 30 days."
      },
      "Objective": {
        "score": 1,
        "evidence": "The objective of this study was to compare the development of long-term chronic kidney disease (CKD) and cardiac conditions postoperatively among patients who did and did not develop acute kidney injury (AKI) following open ERAS surgery for gynecologic malignancy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the 36-month cumulative incidence of CKD."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Blinding": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Out of 378 patients, 51 (13.5%) developed postoperative AKI."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Univariate analysis showed that AKI was associated with CKD (HR=2.17, 95% CI 1.22\u20133.84)."
      },
      "Harms": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      },
      "Funding": {
        "score": 0,
        "evidence": "The study did not provide details on trial registration, randomization, blinding, or funding sources."
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}